Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MV130 for Recurrent Wheezing in Children
NCT01734811Phase 3Completed
- Sponsor
- Inmunotek
- Start
- Oct 2012
- Primary completion
- May 2016
- Modality
- Microbiome Therapeutics, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of MV130 in wheeze, sponsored by Inmunotek. Started Oct 2012; status: completed.
02
Drugs
MV130
03
Conditions
wheeze
Beyond the preview
Go deeper on NCT01734811.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01734811.